SANN.SW Stock — Price, Charts & Analysis

Santhera Pharmaceuticals Holding AG (SANN.SW) has no trailing P/E shown and a forward P/E of 97.18x. This places SANN.SW in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.

SANN.SW trades with 97.18x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether SANN.SW looks overvalued or undervalued.

SANN.SW's P/E of 97.18x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

SANN.SW's trailing EPS is -CHF 3.78 and forward EPS is CHF 0.17.

EPS, or earnings per share, shows how much profit Santhera Pharmaceuticals Holding AG generated for each share. SANN.SW's trailing EPS is -CHF 3.78, and investors usually prefer EPS that is positive and growing over time.

Santhera Pharmaceuticals Holding AG has a market cap of CHF 251.87M, making SANN.SW a small-cap stock based on the current market value shown on Worldtickers.

SANN.SW's latest stock price on Worldtickers is CHF 16.52. The latest move is -CHF 0.44 or -2.59%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

SANN.SW's quote includes a latest price of CHF 16.52. The market open is CHF 17.06. Previous close is CHF 16.96. The intraday range is CHF 15.58 to CHF 17.24.

SANN.SW is down in the latest quote, with a move of -CHF 0.44 or -2.59%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

SANN.SW generated CHF 77.19M in trailing revenue. Revenue growth is 112.70%, which helps show whether demand is expanding or slowing.

SANN.SW's revenue growth is 112.70%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

No, SANN.SW does not show positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is -CHF 49.24M.

Gross margin is 19.66%. Margins show how efficiently Santhera Pharmaceuticals Holding AG turns revenue into profit.

Santhera Pharmaceuticals Holding AG carries CHF 48.95M and holds CHF 22.44M in cash.

SANN.SW holds CHF 22.44M on its balance sheet.

SANN.SW's book value per share is -CHF 0.88.

Institutions hold 11.10% of SANN.SW shares. Insiders hold 14.57% of shares. Ownership mix helps investors understand how much of Santhera Pharmaceuticals Holding AG is held by professional investors and company insiders.

SANN.SW has 15.25M shares outstanding. Float shares are 11.27M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for SANN.SW, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for SANN.SW is CHF 0.17. Revenue growth is 112.70%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

SANN.SW's trailing EPS is -CHF 3.78. Forward EPS is CHF 0.17. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

SANN.SW is in the Healthcare sector. Its earnings multiple is 97.18x. Its latest displayed growth metric is 112.70%. Compare these figures with sector peers before deciding whether Santhera Pharmaceuticals Holding AG is stronger or weaker than average.

SANN.SW trades at CHF 16.52. The stock trades at 97.18x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Santhera Pharmaceuticals Holding AG's fundamentals.

SANN.SW risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is -0.28, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

SANN.SW should be compared with companies in Biotechnology. Its earnings multiple is 97.18x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Santhera Pharmaceuticals Holding AG (SANN.SW) operates in Healthcare, specifically Biotechnology. Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company's lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.

SANN.SW trades on Swiss. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

SANN.SW stock is priced in CHF on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Santhera Pharmaceuticals Holding AG's official website listed on Worldtickers is www.santhera.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Santhera Pharmaceuticals Holding AG employs about 93 people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Santhera Pharmaceuticals Holding AG is headquartered in Pratteln, Switzerland. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

SANN.SW is in the Healthcare sector and the Biotechnology industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

SANN.SW has traded between CHF 9.38 and CHF 18.84 over the past 52 weeks. At CHF 16.52, it is 12.31% below the high and 76.12% above the low. The 52-week range helps gauge long-term price momentum.

SANN.SW is above both its 50-day and 200-day moving averages, which is a common uptrend signal. Its 50-day moving average is CHF 15.40 and its 200-day moving average is CHF 14.67.

SANN.SW's RSI is 66.69. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

SANN.SW's latest RSI reading is 66.69, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for SANN.SW is near CHF 13.86. Key resistance is near CHF 16.90. Breaks above resistance or below support can change the short-term technical setup.

SANN.SW's nearest reported support level is CHF 13.86. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

SANN.SW's nearest reported resistance level is CHF 16.90. A breakout above resistance can improve momentum, especially when volume confirms the move.

SANN.SW trades about 68.85K shares daily on average. The latest displayed volume is 160.89K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

SANN.SW's MACD is 0.20, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

SANN.SW is above both its 50-day and 200-day moving averages, which is a common uptrend signal. RSI is 66.69 (neutral). MACD is bullish. Nearest support is around CHF 13.86. Resistance is around CHF 16.90. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is CHF 15.34 (10.55% from price). MA50 is CHF 15.40 (10.11% from price). MA200 is CHF 14.67 (15.59% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. SANN.SW's MA20 is CHF 15.34. MA50 is CHF 15.40. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

SANN.SW's pivot is near CHF 16.23. Support is near CHF 13.86. Resistance is near CHF 16.90. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for SANN.SW is near CHF 16.27. The next upper resistance zone is near CHF 18.22. These levels help define risk and possible follow-through zones after a breakout or breakdown.

SANN.SW's Bollinger range is roughly CHF 13.62 to CHF 17.06. Band width is near 22.43%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

SANN.SW's ATR-based typical daily range is about 3.60%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 160.89K shares. Average volume is about 68.85K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

SANN.SW's all-time high shown on Worldtickers is CHF 1,389.00. Its all-time low is CHF 5.00. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

SANN.SW has a beta of -0.28, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.